Works matching IS 09697128 AND DT 1999 AND VI 6 AND IP 8

Results: 18

Cellular redox state alters recombinant adeno-associated virus transduction through tyrosine phosphatase pathways.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1427, doi. 10.1038/sj.gt.3300967

By:

Sanlioglu, S;
Engelhardt, J F

Publication type:

Article

pCOR: a new design of plasmid vectors for nonviral gene therapy.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1482, doi. 10.1038/sj.gt.3300968

By:

Soubrier, F;
Cameron, B;
Manse, B;
Somarriba, S;
Dubertret, C;
Jaslin, G;
Jung, G;
Caer, C Le;
Dang, D;
Mouvault, J M;
Scherman, D;
Mayaux, J F;
Crouzet, J

Publication type:

Article

Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1406, doi. 10.1038/sj.gt.3300954

By:

Baranov, A;
Glazkov, P;
Kiselev, A;
Ostapenko, O;
Mikhailov, V;
Ivaschenko, T;
Sabetsky, V;
Baranov, V

Publication type:

Article

A novel dual function retrovirus expressing multidrug resistance 1 and O<sup>6</sup>-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1489, doi. 10.1038/sj.gt.3300962

By:

Jelinek, J;
Rafferty, J A;
Cmejla, R;
Hildinger, M;
Chinnasamy, D;
Lashford, L S;
Ostertag, W;
Margison, G P;
Dexter, T M;
Fairbairn, L J;
Baum, C

Publication type:

Article

Human serum-resistant retroviral vector particles from galactosyl (α1–3) galactosyl containing nonprimate cell lines.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1397, doi. 10.1038/sj.gt.3300963

By:

Mason, J M;
Guzowski, D E;
Goodwin, L O;
Porti, D;
Cronin, K C;
Teichberg, S;
Pergolizzi, R G

Publication type:

Article

Inflammatory responses and their impact on β-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1368, doi. 10.1038/sj.gt.3300958

By:

Lawrence, M S;
Foellmer, H G;
Elsworth, J D;
Kim, J H;
Leranth, C;
Kozlowski, D A;
Bothwell, A L M;
Davidson, B L;
Bohn, M C;
Redmond, D E

Publication type:

Article

Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1475, doi. 10.1038/sj.gt.3300961

By:

Kayaga, J;
Souberbielle, B E;
Sheikh, N;
Morrow, W J W;
Scott-Taylor, T;
Vile, R;
Dalgleish, A G

Publication type:

Article

Adenoviral vectors: prospects for gene delivery to the central nervous system.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1349, doi. 10.1038/sj.gt.3301013

By:

Parks, Robin J;
Bramson, Jonathan L

Publication type:

Article

The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1448, doi. 10.1038/sj.gt.3300964

By:

Pasquini, S;
Deng, H;
Reddy, S T;
Giles-Davis, W;
Ertl, H C J

Publication type:

Article

Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1438, doi. 10.1038/sj.gt.3300965

By:

Zhang, Y P;
Sekirov, L;
Saravolac, E G;
Wheeler, J J;
Tardi, P;
Clow, K;
Leng, E;
Sun, R;
Cullis, P R;
Scherrer, P

Publication type:

Article

Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1415, doi. 10.1038/sj.gt.3300966

By:

Kokoris, M S;
Sabo, P;
Adman, E T;
Black, M E

Publication type:

Article

Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1469, doi. 10.1038/sj.gt.3300969

By:

Haisma, H J;
Pinedo, H M;
van Rijswijk, A;
van der Meulen-Muileman, I;
Sosnowski, B A;
Ying, W;
van Beusechem, V W;
Tillman, B W;
Gerritsen, W R;
Curiel, D T

Publication type:

Article

Adenoviral vectors for in vivo gene delivery to oligodendrocytes: transgene expression and cytopathic consequences.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1360, doi. 10.1038/sj.gt.3300971

By:

Franklin, R J M;
Quick, M M;
Haase, G

Publication type:

Article

A model for long-term transgene expression in spinal cord regeneration studies.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1351, doi. 10.1038/sj.gt.3300972

By:

O’Leary, M T;
Charlton, H M

Publication type:

Article

Adenovirus-mediated expresssion of the murine ecotropic receptor facilitates transduction of human hematopoietic cells with an ecotropic retroviral vector.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1456, doi. 10.1038/sj.gt.3300974

By:

Nathwani, A C;
Persons, D A;
Stevenson, S C;
Frare, P;
McClelland, A;
Nienhuis, A W;
Vanin, E F

Publication type:

Article

Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1380, doi. 10.1038/sj.gt.3300976

By:

Godbey, W T;
Wu, K K;
Hirasaki, G J;
Mikos, A G

Publication type:

Article

Distribution of retroviral vectors and vector producer cells using two routes of administration in rats.

Published in:

Gene Therapy, 1999, v. 6, n. 8, p. 1389, doi. 10.1038/sj.gt.3300983

By:

Kaloss, M;
Linscott, M;
Wey, C;
Lu, P;
Long, Z;
McGarrity, G J;
Otto, E;
Lyons, R M

Publication type:

Article

Opportunities and challenges in targeting genes for therapy.

Published in:

1999

By:

Gruenert, D C

Publication type:

Editorial